- How valuable is being first to market, really?
- Which market factors most affect market share?
- How can portfolio strategy teams provide the best guidance to their organisations?
While pharma companies fight to be first in class or best in class, there are a range of market factors that influence the success – or otherwise – of a new drug. How do you identify the right ones to focus on to deliver the best commercial outcomes?
Share:
In this webinar, Evaluate’s experts will discuss their latest analysis on the real value of being first to market across different therapy areas, and how market share is impacted as new drugs are approved. We’ll also discuss other determinants of market share beyond order of market entry and consider best practices for effective forecasting and managing stakeholder expectations.
